Original Research

Recently published articles about Original Research

JCP
Brexpiprazole for the Treatment of Co-Occurring Schizophrenia and Substance Use Disorder
Original Research

October 13, 2025

This pilot trial suggests that brexpiprazole might be beneficial in reducing substance craving and use and improve quality of life in this difficult-to-treat patient population.
, , , et al
JCP
Depression at 2 Months Postpartum: Results from the French National Perinatal Survey
Original Research

October 8, 2025

The prevalence of postpartum depression (PPD) at 2 months was 16.7%. Factors associated with PPD included age ≤29 or ≥40 years, lower levels of health literacy, and a history...
, , , et al
JCP
Esmethadone (REL-1017) in Patients with Major Depressive Disorder and Antidepressant Tachyphylaxis
Original Research

October 6, 2025

Esmethadone may be a potentially safe and effective adjunctive treatment for patients with MDD and antidepressant tachyphylaxis.
, , , et al
PCC
Access to Primary Care in First-Episode Psychosis
Original Research

October 2, 2025

Improving engagement in primary care is critical for young adults with first-episode psychosis to establish beneficial patterns of health care use and timely access to preventative care.
, , , et al
JCP
Symptom Network Analysis of ADHD and Emotional Symptoms in Adults
Original Research

October 1, 2025

Emotional dysregulation symptoms play a significant role in connecting the core ADHD symptoms, particularly those related to the inattention dimension.
, , , et al
JCP
Emory Treatment Resistance Interview for PTSD—Short Version
Original Research

October 1, 2025

The E-TRIP-S offers a simplified method for assessing treatment resistance among PTSD patients.
, ,

Recent JCP Articles on Original Research

JCP
Treatment with (Es)ketamine in Catatonia: A Systematic Review of Case Reports
Brief Report

October 13, 2025

Recent evidence suggests that NMDA receptor antagonists, such as ketamine, may offer benefit in catatonia. This systematic review was conducted to evaluate the efficacy and safety of ketamine and...
, , , et al
JCP
Dosing Patients With Oral Iron Supplements: Practical Guidance
Clinical and Practical Psychopharmacology

October 8, 2025

The relevance of iron in neuropsychiatry is discussed, with guidance on how to dose oral iron supplements so as to maximize its absorption.
JCP
Beyond the Boxed Warning: A Call for Regulation of Psychiatry’s Most Teratogenic Drug
Commentary

October 6, 2025

The authors assert that while valproate remains invaluable for certain severe conditions, the high risk of teratogenicity means stringent safeguards are needed to regulate its use by individuals capable...
, , , et al

Recent PCC Articles on Original Research

PCC
Improving Community Mental Health Care
Narrative Review

October 9, 2025

This review highlights critical areas for enhancing the quality and sustainability of community mental health services.
, ,
PCC
N-Acetylcysteine for Psychogenic Polydipsia
Case Report

October 9, 2025

The authors describe the clinical management of an outpatient with diagnoses of psychogenic polydipsia, schizophrenia, mild intellectual and developmental disability, and autism spectrum disorder.
, , , et al
PCC
Mosaic Turner Syndrome and Schizophrenia
Case Report

October 7, 2025

This case adds to the literature on Turner syndrome and psychosis and is an example of the heterogeneity of individuals who meet the criteria for treatment-resistant schizophrenia.
, ,

Featured Original Research Research

Newborn Brain Wiring Predicts Social Attention Months Later
news

October 13, 2025

A right-sided social perception pathway in the newborn brain is already active at birth and can predict how socially engaged they become later on.
A New Approach to Mindfulness?
news

October 10, 2025

Watching short, uplifting videos of people overcoming adversity can reduce stress as effectively as guided meditation.
Weekly Mind Reader: Postpartum Depression Haunts One in Six Moms
news

October 10, 2025

This week features new postpartum depression research, successful treatment for Turner syndrome, and a reminder about oral iron supplements.

Expert Consensus on Aripiprazole LAIs in Clinical Practice

Read the full report
Figure shows a syringe and vials with title on aripiprazole monohydrate LAI use in schizophrenia and a red READ NOW button.

Subscribe to read
more articles

Subscribe